There are 2949 resources available
1678P_PR - The impact of COVID-19 pandemic on cancer care: A global collaborative study
Presenter: Abdul Rahman Jazieh
Session: E-Poster Display
Resources:
Abstract
1679P - Determinants of mortality from SARS-CoV-2 infection in European cancer patients
Presenter: David Pinato
Session: E-Poster Display
Resources:
Abstract
1680P - SARS-CoV-2 infections in outpatients with cancer: Most infected patients are asymptomatic carriers without impact on chemotherapy
Presenter: Dirk Hempel
Session: E-Poster Display
Resources:
Abstract
1681P - First results of the COCO study: COVID-19 outcomes in patients with cancer
Presenter: Elia Seguí
Session: E-Poster Display
Resources:
Abstract
1682P - Outcomes of cancer patients undergoing radiotherapy during the COVID-19 outbreak in Wuhan, China
Presenter: Melvin Lee Kiang Chua
Session: E-Poster Display
Resources:
Abstract
1683P - SARS-CoV-2 infection and lung cancer management in Europe
Presenter: Abed Agbarya
Session: E-Poster Display
Resources:
Abstract
1712P - Risk of SARS-CoV-2 infection and outcome after infection: Experience from the day-care unit at CHU Liège in Belgium
Presenter: Marie Lecocq
Session: E-Poster Display
Resources:
Abstract
1713P - Active smoking and severity of COVID-19 infection in cancer patients
Presenter: Garcia De Herreros Marta
Session: E-Poster Display
Resources:
Abstract
1714P - Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score
Presenter: Elia Seguí
Session: E-Poster Display
Resources:
Abstract
1715P - Plinabulin (Plin) is a more favorable option for the prevention of chemotherapy induced neutropenia (CIN) than pegfilgrastim (Peg) during the COVID-19 pandemic
Presenter: Douglas Blayney
Session: E-Poster Display
Resources:
Abstract